Status:

COMPLETED

Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types

Lead Sponsor:

Johnson & Johnson Vision Care, Inc.

Conditions:

Visual Acuity, Slit Lamp Biomicroscopy (Corneal Staining Assessment)

Eligibility:

All Genders

18-69 years

Phase:

NA

Brief Summary

This is a multi-site, randomized, double-masked, contralateral, 2 treatment x 2 period crossover, dispensing, five-visit study to gain clinical insights of the study lenses and solutions.

Eligibility Criteria

Inclusion

  • Potential subjects must satisfy all of the following criteria to be enrolled in the study:
  • Subjects must be 18-69 years of age (inclusive).
  • Subjects must be habitual disposable hydrogel or silicone hydrogel (1-day, 2-week, or monthly replacement schedule) soft lens wearer in both eyes. Habitual is defined as at least one (1) month of contact lens wear where the lenses are worn for a minimum of six (6) hours per day and a minimum of five (5) days per week.
  • Subjects must have best corrected visual acuity of 20/25 (Snellen or equivalent) or better in each eye.
  • The subject's refractive sphere (vertexed) must be between -1.00 and -6.00 D in each eye.
  • The subject's refractive cylinder must be less than or equal to -1.00 D in each eye.
  • The subject must have normal eyes (i.e., no ocular medications or infections of any type).
  • Subjects must possess a functional/usable pair of spectacles and bring them to the visit (only if applicable - to the investigators discretion).
  • Subjects must read, understand, and sign the Statement of Informed Consent.
  • Subjects must appear able and willing to adhere to the instructions set forth in this clinical protocol.

Exclusion

  • Potential subjects who meet any of the following criteria will be excluded from participating in the study:
  • Currently pregnant or breast-feeding.
  • Diabetes
  • Any ocular or systemic allergies or disease which may interfere with contact lens wear (at the discretion of the investigator).
  • Any systemic disease, autoimmune disease, or use of medication which may interfere with contact lens wear (at the discretion of the investigator).
  • Any infectious diseases (e.g. hepatitis, tuberculosis) or a contagious immunosuppressive disease (eg, HIV), by self-report.
  • Current habitual use of Restasis, Xiidra, ocular steroids, or any medication (RX or OTC) that may interfere with contact lens wear (at the discretion of the investigator).
  • Grade 2 or greater corneal staining or conjunctival injection on the FDA scale.
  • Clinically significant (Grade 3 or greater on the FDA scale) corneal edema, corneal vascularization, or any other abnormalities of the cornea (excluding corneal staining) which would contraindicate contact lens wear.
  • Clinically significant (Grade 3 or greater on the FDA scale) tarsal abnormalities which might interfere with contact lens wear.
  • Any active ocular abnormalities/conditions that may interfere with contact lens wear (at the discretion of the investigator).
  • Any corneal distortion due to previous rigid gas permeable lens wear, surgery or pathology.
  • History of any ocular or corneal surgery (eg, RK, PRK, LASIK).
  • Habitual contact lens wear modality as extended wear.
  • Participation in any pharmaceutical or medical device related clinical trial within 7 days prior to study enrollment.
  • History of binocular vision abnormality or strabismus.
  • Habitual wearers of rigid gas permeable lens within the past 3 months.
  • Employees of investigational clinic (investigator, coordinator, and technician etc.) or family members of employees of the investigational clinic by self-report

Key Trial Info

Start Date :

February 7 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 19 2018

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT03466060

Start Date

February 7 2018

End Date

June 19 2018

Last Update

October 2 2019

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Southern California College of Optometry

Anaheim, California, United States, 92807

2

University of California, Berkeley School of Optometry

Berkeley, California, United States, 94720

3

Vue Optical Boutique

Jacksonville, Florida, United States, 32205

4

The Ohio State University

Columbus, Ohio, United States, 43210

Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types | DecenTrialz